Merck KGAA has named Kamal Shah head of its new global drug safety department's innovation unit. Shah is a board certified anesthesiologist and has held management and leadership roles in medical affairs, clinical development and drug safety at PPD, Bristol-Myers Squibb Co., Pfizer Ltd. and Celgene Corp.
C4X Discovery Holdings PLC has appointed its chief scientific officer, Craig Fox, and chief financial officer (CFO), Brad Hoy, to its board of directors. Hoy has been appointed permanent CFO following a period as interim CFO. He carries over 20 years of pharmaceutical and biotechnology experience and has held various senior financial and general management positions in the UK and US. Previously, Hoy was CFO of Plethora Solutions Holdings PLC. CEO of Xcellsyz Ltd